Press release content from Globe Newswire. The AP news staff was not involved in its creation.
RotaChrom Technologies Partners With Cyclolab to Increase Production of COVID-19 Treatment
RotaChrom TechnologiesFebruary 8, 2021 GMT
New Partnership Aims to Develop More Efficient, Cost-Effective Process to Purify Remdesivir
Budapest, Hungary, Feb. 08, 2021 (GLOBE NEWSWIRE) via NewMediaWire RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, announced today the launch of a collaboration with Cyclolab Cyclodextrin Research and Development Laboratory Ltd. (“Cyclolab″), a cyclodextrin research, development and manufacturing company. This strategic partnership between Cyclolab and RotaChrom aims to develop a more efficient and cost-effective process to purify Remdesivir, which is a widely used treatment option for COVID-19.